Cargando…

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients

Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of...

Descripción completa

Detalles Bibliográficos
Autor principal: Lamorde, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512449/
http://dx.doi.org/10.7448/IAS.15.6.18079
_version_ 1782251728514580480
author Lamorde, M
author_facet Lamorde, M
author_sort Lamorde, M
collection PubMed
description Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of an HIV Research Trust scholarship recipient in Uganda. The work highlights the need for post-marketing pharmacokinetic studies in the target populations in order to optimize therapy for patients in resource-limited settings.
format Online
Article
Text
id pubmed-3512449
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-35124492012-12-03 Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients Lamorde, M J Int AIDS Soc Oral Abstract – O141 Clinical pharmacokinetic data on antiretroviral drugs are scarce in African HIV-1-positive patients. Most available pharmacokinetic data are derived from ethnically distinct Caucasian research volunteers. This presentation will focus on the clinical pharmacokinetics training and research outputs of an HIV Research Trust scholarship recipient in Uganda. The work highlights the need for post-marketing pharmacokinetic studies in the target populations in order to optimize therapy for patients in resource-limited settings. International AIDS Society 2012-11-11 /pmc/articles/PMC3512449/ http://dx.doi.org/10.7448/IAS.15.6.18079 Text en © 2012 Lamorde M. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Abstract – O141
Lamorde, M
Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
title Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
title_full Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
title_fullStr Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
title_full_unstemmed Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
title_short Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
title_sort clinical pharmacokinetics of antiretroviral drugs in ugandan patients
topic Oral Abstract – O141
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512449/
http://dx.doi.org/10.7448/IAS.15.6.18079
work_keys_str_mv AT lamordem clinicalpharmacokineticsofantiretroviraldrugsinugandanpatients